SonoScape Launches Latest Generation Ultrasound System
The ELITE series merges artificial intelligence and augmented processing capabilities.
SonoScape Medical has launched its latest ultrasound system – the ELITE series, the company announced this week.
By combining artificial intelligence (AI) solutions and greater processing capabilities, the system is designed to improve diagnostic capabilities, company officials said.
“We developed the ELITE series in intensive cooperation with clinical experts,” said Zhou Wenping, head of research and development at SonoScape Medical. “I believe that this new series will substantially increase diagnostic confidence and empower clinicians to take advantage of the next level technologies, such as CEUS.”
SonoScape ELITE Courtesy: SonoScape Medical Corporation
This system adds AI-based automated tools, such as S-Fetus, Auto OB and lucid imaging technologies, as standard features on SonoScape’s Wis+ intelligent ultrasound platform. According to company details, the system offers four times the data processing capability and 10 times the system response rate of previous system iterations. In addition, it features advanced rendering models, including S-Live Silhouette and Color 3D.
The focus, officials said, is on optimizing image acquisition and diagnostic patient management workflows to help hospitals and clinics improve their performance, the experiences of their patients and staff, and health outcomes, while lowering the cost of care.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
